<

HBM HEALTHCARE INVESTMENTS AG (FRA:CH001262) HBM Healthcare Investments publishes net asset value per share of CHF 253.59 as at 31 December 2022

Transparency directive : regulatory news

03/01/2023 17:47

HBM Healthcare Investments AG / Key word(s): Quarter Results
HBM Healthcare Investments publishes net asset value per share of CHF 253.59 as at 31 December 2022

03-Jan-2023 / 17:47 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.


HBM Healthcare Investments suffered a negative performance for the calendar year 2022 in a declining market. The net asset value per share (NAV) declined by 21.7 percent to CHF 253.59. The share price fell by a much greater 37.8 percent to CHF 201.00.

The relevant market indices in the healthcare sector showed a negative performance across the board. The broad-based MSCI World Health Care Index recorded a minus of 3.9 percent. The biotech segment, as measured by the Nasdaq Biotechnology Index (NBI) and the SPDR S&P Biotech (XBI), declined significantly more, by 9.1 per cent and 25.0 per cent respectively. 

Performance for the 9 months of the financial year 2022/2023

For the first nine months of the 2022/2023 financial year ending on 31 March, the NAV decreased by 7.8 per cent. Therefore, a net loss of around CHF 155 million is expected for this period.

Notwithstanding the market-driven decline in value, the HBM Healthcare Investments portfolio remains well positioned for the market environment, which continues to be fraught with uncertainty, thanks to the balanced mix of promising private and listed companies and a high level of cash and cash equivalents of CHF 282 million. 

These figures are the preliminary results based on the current status of the closing process. The December 2022 quarterly report will be published on 20 January 2023.

Contact
For further information, please contact Dr Andreas Wicki on +41 41 710 75 77, or at andreas.wicki@hbmhealthcare.com.



End of Inside Information
Language: English
Company: HBM Healthcare Investments AG
Bundesplatz 1
6300 Zug
Switzerland
Phone: +41438887171
Fax: +41438887172
E-mail: info@hbmhealthcare.com
Internet: https://www.hbmhealthcare.com
ISIN: CH0012627250
Valor: 1262725
Listed: SIX Swiss Exchange
EQS News ID: 1526615

 
End of Announcement EQS News Service

1526615  03-Jan-2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1526615&application_name=news&site_id=symex

HBM HEALTHCARE INVESTMENTS AG's latest news


16/05/2024 17:47
08/05/2024 18:37
01/05/2024 17:47
16/04/2024 17:47
02/04/2024 17:48
02/04/2024 17:46
18/03/2024 17:47
01/03/2024 17:47
16/02/2024 17:47
01/02/2024 17:47


Other stories

16/05/2024 22:43
16/05/2024 18:01
16/05/2024 17:01
16/05/2024 14:13
16/05/2024 14:38
16/05/2024 22:30
16/05/2024 17:50
16/05/2024 18:52
16/05/2024 19:55
16/05/2024 11:42
16/05/2024 16:32
16/05/2024 18:43
16/05/2024 14:57
16/05/2024 15:06
16/05/2024 20:25
16/05/2024 15:29
16/05/2024 17:50
16/05/2024 16:20
16/05/2024 18:24
16/05/2024 12:13
16/05/2024 20:27
16/05/2024 16:07
16/05/2024 22:04
16/05/2024 18:53
16/05/2024 16:32
16/05/2024 13:15
16/05/2024 22:45
16/05/2024 22:53
16/05/2024 21:35
16/05/2024 22:14
15/05/2024 22:40
16/05/2024 21:24
16/05/2024 09:24
15/05/2024 11:19
16/05/2024 13:00
16/05/2024 10:02
16/05/2024 17:46
16/05/2024 15:23